Safety and Anti-HIV Activity of Capravirine Alone and in Combination With Other Anti-HIV Drugs

NCT00005673 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

46

Enrollment

NIH

Sponsor class

Conditions

Healthy
HIV Infection

Interventions

DRUG: Capravirine

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)